CheckMyRecalls

Teva Pharmaceuticals USA, Inc recalls Amoxicillin and Clavulanate…

Teva Pharmaceuticals USA, Inc recalls Amoxicillin and Clavulanate Potassium for Oral Suspension USP

Published
12 Nov 2025
Units affected
4680 cartons
Agency
FDA
Country
United States

The hazard

Subpotent drug; Clavulanate Potassium component

Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What to do

Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.

  • Check the lot number on the box or bottle.
  • Talk to your pharmacist or doctor before stopping any prescribed medicine.
  • Return the product to the pharmacy for safe disposal.
Read the official FDA notice

Product details

Amoxicillin and Clavulanate Potassium for Oral Suspension USP, 200 mg/28.5 mg per 5mL, 100 mL (when reconstituted), Rx only, manufactured in Canada by: Teva Canada Limited, Toronto, Canada M1B 2K9; Manufactured For: Teva Pharmaceuticals USA, Inc., Parsippany, NJ 07054 NDC 0093-2277-7.

Brand / company
Teva Pharmaceuticals USA, Inc
Codes / lots
Lot # 100062316, Exp Date: 01/2026
Distribution
Distributed in three (3) States: MS, OH, CA.
Recall status
Ongoing

Source: U.S. Food and Drug Administration, published 12 Nov 2025. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.